The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Singh Shawn since 2013.
This trader's CIK number is 1412071.
At the time of last reporting, Singh Shawn was the CHIEF EXECUTIVE OFFICER of Vistagen Therapeutics, Inc.. (stock ticker symbol VTGN).
Also see all insider trading activities at Vistagen Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | VTGN | 600,000 | $103,199 | 0 | $0 | 100,000 | $100,000 |
| 2021 | VTGN | 0 | $0 | 0 | $0 | 5,000 | $7,500 |
| 2019 | VTGN | 0 | $0 | 0 | $0 | 25,375 | $38,062 |
| 2013 | VTGN | 0 | $0 | 0 | $0 | 60,000 | $38,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-17 | VTGN | Buy | 600,000 | .17 | 103,199 |
| 2022-05-12 | VTGN | Option Ex | 100,000 | 1.00 | 100,000 |
| 2021-04-23 | VTGN | Option Ex | 5,000 | 1.50 | 7,500 |
| 2019-01-14 | VTGN | Option Ex | 25,375 | 1.50 | 38,062 |
| 2013-10-15 | VSTA | Option Ex | 10,000 | .64 | 6,400 |
| 2013-06-27 | VSTA | Option Ex | 50,000 | .64 | 32,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Singh Shawn (CHIEF EXECUTIVE OFFICER of Vistagen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.